Hepatofit Forte, 63 capsules

About the product

Hepatofit Forte is intended for people who have an elevated level of transaminases. It is recommended in the following conditions: Hepatic steatosis Acute and chronic hepatitis of various aetiologies Chronic alcohol consumption, chronic medication use Exposure to toxic compounds The efficacy was confirmed by a clinical study carried out at the Fundeni Clinical Institute. The clinical effects were also confirmed by paraclinical laboratory investigations (decrease in transaminases in over 85% of patients with an average of 30 units/litre) and by imaging (regression of hepatic steatosis from a severe stage to a moderate stage). By following the recommended directions for use, after three months, a decrease in transaminases by at least 70% of the excess over normal values is obtained in over 85% of the monitored cases of hepatic steatosis.

Storage